Zurich Cantonal Bank’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.67M Buy
+32,061
New +$2.54M 0.01% 887
2025
Q4
Sell
-14,842
Closed -$1M 3072
2025
Q3
$840K Buy
14,842
+1,583
+12% +$71.4K ﹤0.01% 1392
2025
Q2
$579K Buy
13,259
+1,911
+17% +$65.8K ﹤0.01% 1570
2025
Q1
$311K Sell
11,348
-606
-5% -$22.1K ﹤0.01% 1874
2024
Q4
$481K Buy
11,954
+665
+6% +$30K ﹤0.01% 1655
2024
Q3
$534K Buy
11,289
+915
+9% +$40.4K ﹤0.01% 1520
2024
Q2
$310K Sell
10,374
-1
-0% -$35 ﹤0.01% 1810
2024
Q1
$417K Buy
10,375
+4,335
+72% +$155K ﹤0.01% 1596
2023
Q4
$154K Hold
6,040
﹤0.01% 2232
2023
Q3
$84K Hold
6,040
﹤0.01% 2431
2023
Q2
$139K Hold
6,040
﹤0.01% 2153
2023
Q1
$179K Buy
6,040
+1,055
+21% +$34K ﹤0.01% 1944
2022
Q4
$124K Buy
4,985
+1,225
+33% +$32.7K ﹤0.01% 2138
2022
Q3
$82K Hold
3,760
﹤0.01% 2369
2022
Q2
$74K Hold
3,760
﹤0.01% 2431
2022
Q1
$159K Buy
3,760
+488
+15% +$20.6K ﹤0.01% 2037
2021
Q4
$208K Buy
3,272
+1,467
+81% +$85.4K ﹤0.01% 2042
2021
Q3
$106K Buy
+1,805
New +$105K ﹤0.01% 2307

Other funds holding KYMR